HTC
RLAY icon

Hershey Trust Company’s Relay Therapeutics RLAY Stock Holding History

Hershey Trust Company’s Portfolio RLAY Stock Details RLAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-59,360
Closed -$2.17M – 40
2021
Q2 		$2.17M Hold
59,360
– – 0.02% 11
2021
Q1 		$2.05M Buy
+59,360
New +$2.58M 0.02% 9

Other funds holding RLAY

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Hershey Trust Company's RLAY Position: Q3 2021 in Review

Hershey Trust Company sold out of Relay Therapeutics (RLAY) in Q3 2021, closing a stake of 59,360 shares — an estimated $2.17M sold.

Hershey Trust Company first reported a position in RLAY in Q1 2021 and held it in 2 quarters. The position peaked at $2.17M in Q2 2021. 132 funds tracked by Wall St. Rank hold RLAY as of Q3 2021.

  • Hershey Trust Company reported no remaining Relay Therapeutics position as of Q3 2021 after selling out during the quarter.
  • Hershey Trust Company sold 59,360 Relay Therapeutics shares in Q3 2021, an estimated $2.17M.
  • Hershey Trust Company first reported a position in Relay Therapeutics in Q1 2021 and held it in 2 quarters.
  • Hershey Trust Company's Relay Therapeutics position peaked at $2.17M in Q2 2021.
  • 132 funds tracked by Wall St. Rank held Relay Therapeutics as of Q3 2021.

Based on Hershey Trust Company's 13F filing for Q3 2021, filed 12 Nov 2021.